Medifast, Inc. MED
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 227.52M | 316.93M | 346.10M | 385.79M | 429.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 227.52M | 316.93M | 346.10M | 385.79M | 429.70M |
| Cost of Revenue | 70.23M | 70.23M | 76.16M | 83.35M | 91.18M |
| Gross Profit | 157.29M | 157.29M | 180.54M | 213.03M | 249.11M |
| SG&A Expenses | 172.80M | 172.80M | 192.79M | 221.06M | 235.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 245.13M | 338.62M | 364.53M | 400.00M | 422.89M |
| Operating Income | -17.61M | -21.69M | -18.43M | -14.21M | 6.80M |
| Income Before Tax | -11.31M | -11.31M | -5.45M | -2.98M | 4.68M |
| Income Tax Expenses | 12.03M | 12.03M | 12.31M | 13.43M | 2.17M |
| Earnings from Continuing Operations | -23.34 | -23.34 | -17.76 | -16.41 | 2.51 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.34M | -25.60M | -20.02M | -18.67M | 248.00K |
| EBIT | -17.61M | -21.69M | -18.43M | -14.21M | 6.80M |
| EBITDA | -7.22M | -7.84M | -3.98M | 30.00K | 20.76M |
| EPS Basic | -3.69 | -2.33 | -1.82 | -1.70 | 0.02 |
| Normalized Basic EPS | -1.76 | -0.91 | -0.58 | -0.36 | 0.79 |
| EPS Diluted | -3.69 | -2.33 | -1.83 | -1.71 | 0.01 |
| Normalized Diluted EPS | -1.76 | -0.91 | -0.58 | -0.36 | 0.79 |
| Average Basic Shares Outstanding | 44.31M | 44.12M | 43.98M | 43.92M | 43.87M |
| Average Diluted Shares Outstanding | 44.31M | 44.12M | 44.05M | 43.99M | 43.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.73% | -0.66% | -0.44% | -1.04% | 78.63% |